outbreak
enteroviru
enceph
report
unit
state
europ
australia
japan
brazil
malaysia
sinc
origin
character
california
outbreak
three
larg
outbreak
dozen
fatal
case
occur
bulgaria
hungari
malaysia
respect
largest
sever
epidem
date
occur
taiwan
total
case
handfootandmouth
diseas
herpangina
hfmdha
report
sever
neurolog
complic
andor
pulmonari
edema
report
case
children
die
fatal
case
fulmin
pulmonari
edema
howev
infect
caus
divers
symptom
rang
none
fatal
remain
unknown
differ
host
infect
rang
clinic
outcom
perhap
rang
relat
virul
load
viru
particular
host
factor
date
relationship
found
genotyp
clinic
outcom
virul
factor
clarifi
possibl
host
factor
especi
host
immun
respons
may
ultim
import
clinic
outcom
clarifi
sever
infect
pathogenesi
investig
factor
cellular
versu
humor
immun
respons
correl
clinic
outcom
humor
immun
humor
immun
neutral
antibodi
igm
measur
igm
measur
onset
diseas
neutral
antibodi
evalu
time
measur
cellular
immun
laboratori
method
measur
neutral
antibodi
follow
standard
protocol
neutral
test
microtit
plate
serum
sampl
inactiv
min
serial
dilut
mix
incub
h
dilut
serum
contain
one
hundr
tissu
cultur
infect
dose
strain
genbank
access
number
microtit
plate
two
replic
well
use
per
serum
dilut
microtit
plate
seed
rhabdomyosarcoma
cell
cell
per
ml
incub
atmospher
test
run
cell
control
serum
control
viru
back
titrat
cytopath
effect
observ
invert
microscop
incub
serotit
determin
cytopath
effect
observ
viru
back
titrat
microtit
plate
fix
glutaraldehyd
stain
crystal
violet
seroposit
defin
serotit
igm
detect
isol
amplifi
purifi
antigen
use
elisa
whose
sensit
specif
respect
isol
peripher
blood
mononuclear
cell
pbmc
blood
sampl
heparin
subject
ficollhypaqu
pharmacia
diagnost
ab
uppsala
sweden
gradient
centrifug
cell
interfac
remov
care
wash
twice
pb
isol
pbmc
cultur
roundbottom
micropl
cell
per
well
ml
cultur
medium
rpmi
medium
supplement
mm
glutamin
mm
sodium
pyruv
penicillin
mgml
streptomycin
human
ab
serum
biocel
laboratori
inc
rancho
domingnez
ca
addit
pbmc
stimul
phytohemagglutinin
pha
differ
concentr
whole
viru
antigen
genbank
access
number
absenc
antigen
serv
control
whole
viru
antigen
purifi
sucros
gradient
centrifug
rpm
h
concentr
viru
measur
use
biorad
protein
assay
reagent
incub
supernat
collect
assay
product
helper
helper
cytokin
chemokin
eotaxin
rant
measur
protein
array
kit
fast
quant
microspot
assay
shleicher
schuell
dassel
germani
assay
triplic
detect
level
il
interleukin
tumor
necrosi
pgml
respect
detect
level
interferon
pgml
eotaxin
mcp
monocyt
chemoattract
protein
mip
macrophag
inflammatori
protein
rant
regul
activ
normal
express
secret
pgml
respect
prolifer
respons
measur
end
cultur
period
cultur
mci
amersham
buckinghamshir
england
ad
well
h
incorpor
radioact
measur
parkard
instrument
co
inc
meriden
ct
data
taken
triplic
well
mean
number
count
per
minut
cpm
stimul
index
calcul
formula
cpm
incorpor
respons
antigen
divid
cpm
incorpor
absenc
antigen
time
lymphocyt
prolifer
respons
pbmc
one
healthi
individu
stimul
phytohemagglutinin
pha
use
experiment
control
pha
stimul
index
rang
data
analyz
sa
statist
packag
version
sa
institut
cari
nc
limit
case
number
valu
distribut
normal
use
kruskalw
test
mannwhitney
utest
continu
variabl
test
use
categor
data
wilcoxon
sign
rank
test
use
compar
cellular
cytokin
chemokin
respons
without
antigen
stimul
prevent
confound
effect
age
sex
immun
respons
multipl
logist
regress
analysi
use
calcul
adjust
p
valu
cellular
humor
immun
concomit
adjust
age
sex
p
consid
statist
signific
humor
immun
shown
fig
neutral
antibodi
titer
differ
significantli
among
three
group
differ
sever
p
kruskalw
test
age
gender
affect
neutral
antibodi
titer
significantli
either
p
p
mannwhitney
utest
respect
phastimul
index
shown
fig
case
pulmonari
edema
significantli
lower
phastimul
lymphocyt
prolifer
median
phastimul
index
rang
comparison
case
median
phastimul
index
rang
median
phastimul
index
case
one
pulmonari
edema
case
phastimul
index
p
test
wherea
nonpulmonari
edema
case
age
gender
affect
phastimul
index
significantli
p
p
test
respect
adjust
age
gender
case
pulmonari
edema
still
significantli
associ
lower
rate
phastimul
index
p
multipl
logist
regress
analysi
stimul
index
doserel
higher
dose
antigen
stimul
induc
higher
lymphocyt
prolifer
respons
although
lymphocyt
prolifer
higher
uncompl
case
statist
differ
lymphocyt
prolifer
found
pulmonari
edema
case
case
p
p
p
concentr
respect
highest
stimul
index
level
shown
fig
median
index
case
four
pulmonari
edema
case
index
wherea
nonpulmonari
edema
case
p
test
overal
peak
si
includ
pulmonari
edema
case
cn
case
uncompl
case
p
test
age
gender
affect
index
significantli
p
p
test
respect
either
differ
cytokin
chemokin
respons
peripher
mononuclear
cell
without
antigen
stimul
shown
tabl
comparison
condit
absenc
antigen
antigen
stimul
induc
signific
increas
cellular
cytokin
signific
decreas
cytokin
median
increas
pgml
median
decreas
pgml
well
increas
proinflammatori
cytokin
median
increas
pgml
median
increas
pgml
median
increas
pgml
overal
stimul
posit
effect
cellular
cytokin
proinflammatori
cytokin
respons
effect
mildli
neg
effect
cytokin
stimul
certain
cellular
chemokin
respons
significantli
increas
includ
median
increas
pgml
median
increas
pgml
median
increas
pgml
median
increas
pgml
median
increas
pgml
rant
median
increas
pgml
observ
signific
increas
cellular
respons
rant
signific
decreas
compar
cellular
respons
cytokineschemokin
sever
case
case
pulmonari
edema
found
significantli
lower
cellular
fig
p
lower
cellular
lower
cellular
lower
cellular
respons
lower
cellular
respons
comparison
case
case
pulmonari
edema
percentag
increas
median
level
cellular
lowest
tabl
uncompl
case
highest
percentag
increas
median
level
cellular
tabl
age
gender
affect
cellular
cytokin
respons
significantli
age
gender
adjust
percentag
increas
cellular
cytokin
still
significantli
differ
among
three
group
differ
clinic
sever
p
fig
contrast
case
cn
involv
uncompl
case
decreas
median
level
cellular
respons
stimul
wherea
none
pulmonari
edema
case
decreas
cellular
respons
p
gener
antigen
enhanc
cellular
cytokin
proinflammatori
cytokin
chemokin
respons
reduc
cellular
cytokin
respons
case
cn
involv
uncompl
case
howev
antigen
littl
effect
cellular
cytokin
chemokin
respons
case
brainstem
enceph
plu
pulmonari
edema
studi
suggest
cellular
immun
rather
humor
immun
may
associ
clinic
outcom
infect
age
gender
may
influenc
immun
howev
demonstr
cellular
immun
pha
stimul
index
cellular
cytokin
respons
significantli
weaker
case
pulmonari
edema
case
age
gender
adjust
contrari
humor
immun
neutral
antibodi
differ
significantli
among
case
differ
clinic
sever
studi
exploratori
studi
small
number
case
investig
prospect
result
must
valid
prospect
immunolog
studi
case
host
immun
genet
studi
sever
case
pulmonari
edema
lower
cellular
cytokin
coupl
lower
lymphocyt
prolifer
respons
higher
incid
sever
diseas
found
children
age
might
explain
weaker
cellular
immun
hypothes
lower
cellular
immun
may
delay
viral
kill
clearanc
thu
result
viral
dissemin
sustain
system
inflammatori
respons
subsequ
pulmonari
edema
host
genet
factor
may
also
play
import
role
requir
investig
yang
kd
et
al
report
patient
ev
meningoenceph
higher
frequenc
gg
genotyp
polymorph
cytotox
lymphocyt
posit
exon
control
subject
without
meningoenceph
case
differ
specif
ev
neutral
antibodi
titer
group
studi
humor
immun
affect
clinic
outcom
infect
either
result
two
studi
suggest
younger
children
genet
involv
decreas
cellular
rather
humor
respons
may
link
sever
ev
infect
studi
control
differ
age
patient
tri
three
present
truli
valid
conclus
regard
differ
cellmedi
immun
respons
brainstem
enceph
plu
pulmonari
edema
group
establish
use
age
match
control
cn
involv
uncompl
diseas
group
anoth
queri
whether
matern
could
import
later
cellular
immun
respons
antibodi
make
lower
cellular
immun
respons
youngest
subject
matern
antibodi
might
administr
live
viral
vaccin
howev
seroepidemiolog
studi
done
show
children
children
neutral
antibodi
children
might
get
antibodi
natur
infect
rather
matern
antibodi
result
suggest
even
youngest
group
case
seldom
matern
antibodi
lower
cellular
immun
might
relat
caus
rather
matern
antibodi
previou
studi
report
patient
pulmonari
edema
dramat
high
blood
valu
tumor
necrosi
white
blood
cell
count
glucos
level
find
suggest
combin
cn
system
inflammatori
respons
may
trigger
cardiopulmonari
collaps
anoth
studi
patient
pulmonari
edema
show
signific
immunomodul
elev
well
lower
circul
tcell
tcell
natur
killer
cell
also
suggest
combin
extens
system
cn
inflammatori
respons
lymphocyt
deplet
appear
respons
pathogenesi
pulmonari
edema
suggest
treatment
vari
sinc
case
pulmonari
edema
lower
cellular
immun
ration
treatment
may
involv
regimen
enhanc
cellular
immun
case
poliomyel
treatment
agedepend
poliomyelitissuscept
mice
protect
paralyt
diseas
recent
studi
also
shown
synerg
inhibit
replic
rna
dna
virus
scagnolari
et
al
investig
effect
ifn
replic
sever
acut
respiratori
syndromeassoci
coronaviru
sarscov
find
although
sarscov
moder
sensit
weakli
sensit
combin
strong
synergist
effect
viru
replic
two
studi
impli
treatment
sever
infect
anim
clinic
trial
mandatori
prove
efficaci
immunomodul
addit
use
antivir
agent
decreas
replic
may
also
benefici
anim
studi
ongo
topic
liu
et
al
studi
earli
administr
recombin
mous
protect
mice
infect
vitro
analysi
virusinduc
death
show
human
type
interferon
exert
direct
protect
effect
interferon
may
play
import
role
control
infect
replic
current
vaccin
sinc
major
cytokin
respons
mononuclear
cell
challeng
cytokin
induct
cellular
respons
may
critic
vaccin
develop
prevent
sever
diseas
therefor
ideal
vaccin
trigger
adequ
immun
cellular
humor
system
conclus
found
cellular
immun
rather
humor
immun
may
relat
clinic
outcom
infect
case
decreas
cellular
immun
plu
lower
cellular
cytokinechemokin
respons
may
prone
dissemin
infect
subsequ
pulmonari
edema
